MedPath

The Acute Effect of Moderate Intensity Stair-Climbing on Postprandial Blood Glucose

Not Applicable
Completed
Conditions
Postprandial Hyperglycemia
Interventions
Other: Stair-climbing
Registration Number
NCT03400774
Lead Sponsor
San Diego State University
Brief Summary

This study aims to investigate the effect of moderate intensity stair-climbing bouts of various durations on postprandial blood glucose. Participants will perform a standard oral glucose tolerance test (OGTT) using 75g of dextrose and with fingerstick blood glucose measurements at baseline and every 15 minutes after consuming the drink for one hour. On separate subsequent visits, participants will perform the same OGTT combined with three stair-climbing bouts lasting 1, 3, and 10 minutes starting 27, 25, and 18 minutes respectively after finishing the drink. Participants performed maximal aerobic capacity (VO2max) using a ramp treadmill test in order to assess the relative intensity of each stairclimbing trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Defined as low risk per the American College of Sports Medicine (ACSM, Guidelines for Exercise Testing & Exercise Prescription, 20014 pg 30)
  • Physical Activity Recall Questionnaire (PAR-Q) screening
Exclusion Criteria
  • Glucose intolerance
  • Diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ControlStair-climbingOral glucose tolerance test with no stair-climbing
1 minuteStair-climbingOral glucose tolerance test with 1 minute of stair-climbing
3 minutesStair-climbingOral glucose tolerance test with 3 minutes stair-climbing
10 minutesStair-climbingOral glucose tolerance test with 10 minutes stair-climbing
Primary Outcome Measures
NameTimeMethod
Postprandial Blood Glucose1 hour

Postprandial blood glucose after various durations of stair-climbing

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath